1. 基本信息
品系名称:B6-Tg(CAG- hPDL-1)5Vst mPDL-1em1Vst/Vst
常用名:mPDL-1null PD-1人源化必威; hPD-1/mPDL-1null必威
背景:C57BL/6NCrl
毛色:黑色
品系建立:
采用转基因的方法,构建CAG- hPDL-1表达载体,酶切分离表达载体片段,将该片段注射到C57BL/6NCrl必威的原核中。在后代中筛选到合适表达量的阳性必威,与mPD-L1null必威交配,获得同时敲除mPDL-1和过表达hPDL-1的必威。
2. 应用领域
-人源化和癌症治疗
-免疫治疗
-药物筛选
3. 参考文献
(1)Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.Yeo MK, Choi SY, Seong IO, Suh KS, Kim JM, Kim KH.Hum Pathol. 2017 Oct; 68: 103-111. doi: 10.1016/j.humpath.2017.08.016. Epub 2017 Aug 26.
(2)Gene code CD274/PD-L1: from molecular basis toward cancer immunotherapy.Fabrizio FP, Trombetta D, Rossi A, Sparaneo A, Castellana S, Muscarella LA.Ther Adv Med Oncol. 2018 Dec 17;10:15598. doi: 10.1177/15598. eCollection 2018.